1. Home
  2. STXS vs RDCM Comparison

STXS vs RDCM Comparison

Compare STXS & RDCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STXS
  • RDCM
  • Stock Information
  • Founded
  • STXS 1990
  • RDCM 1985
  • Country
  • STXS United States
  • RDCM Israel
  • Employees
  • STXS N/A
  • RDCM N/A
  • Industry
  • STXS Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • RDCM Computer peripheral equipment
  • Sector
  • STXS Health Care
  • RDCM Technology
  • Exchange
  • STXS Nasdaq
  • RDCM Nasdaq
  • Market Cap
  • STXS 189.8M
  • RDCM 157.9M
  • IPO Year
  • STXS 2004
  • RDCM 1997
  • Fundamental
  • Price
  • STXS $2.27
  • RDCM $11.73
  • Analyst Decision
  • STXS Strong Buy
  • RDCM Strong Buy
  • Analyst Count
  • STXS 2
  • RDCM 1
  • Target Price
  • STXS $4.50
  • RDCM $14.00
  • AVG Volume (30 Days)
  • STXS 457.1K
  • RDCM 67.9K
  • Earning Date
  • STXS 11-11-2024
  • RDCM 01-29-2025
  • Dividend Yield
  • STXS N/A
  • RDCM N/A
  • EPS Growth
  • STXS N/A
  • RDCM 660.55
  • EPS
  • STXS N/A
  • RDCM 0.46
  • Revenue
  • STXS $25,143,000.00
  • RDCM $58,755,000.00
  • Revenue This Year
  • STXS $1.16
  • RDCM $18.92
  • Revenue Next Year
  • STXS $55.65
  • RDCM $11.27
  • P/E Ratio
  • STXS N/A
  • RDCM $25.60
  • Revenue Growth
  • STXS N/A
  • RDCM 17.80
  • 52 Week Low
  • STXS $1.66
  • RDCM $7.70
  • 52 Week High
  • STXS $3.29
  • RDCM $12.84
  • Technical
  • Relative Strength Index (RSI)
  • STXS 51.98
  • RDCM 49.07
  • Support Level
  • STXS $2.20
  • RDCM $11.46
  • Resistance Level
  • STXS $2.46
  • RDCM $12.32
  • Average True Range (ATR)
  • STXS 0.14
  • RDCM 0.56
  • MACD
  • STXS -0.01
  • RDCM -0.10
  • Stochastic Oscillator
  • STXS 42.71
  • RDCM 9.63

About STXS Stereotaxis Inc.

Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service and accessories stream. The company generates the majority of revenue from the United States.

About RDCM Radcom Ltd.

Radcom Ltd Ltd is engaged in providing network intelligence, 5G ready cloud-native, network intelligence solutions for telecom operators transitioning to 5G. The company has a network intelligence solution for 5G namely Radcom ACE. Its products consist of Radcom Network Visibility, Radcom Service Assurance, and Radcom Network Insights. It has offices in Israel, the United States, Brazil, and India. Key revenue is derived from sales in North America.

Share on Social Networks: